0001250853-21-000039.txt : 20210318 0001250853-21-000039.hdr.sgml : 20210318 20210318163527 ACCESSION NUMBER: 0001250853-21-000039 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210317 FILED AS OF DATE: 20210318 DATE AS OF CHANGE: 20210318 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bevers Denise CENTRAL INDEX KEY: 0001593865 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36225 FILM NUMBER: 21754815 MAIL ADDRESS: STREET 1: C/O KINDRED BIOSCIENCES, INC. STREET 2: 1555 BAYSHORE HIGHWAY, SUITE 200 CITY: BURLINGAME STATE: CA ZIP: 94010 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kindred Biosciences, Inc. CENTRAL INDEX KEY: 0001561743 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 461160142 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1555 BAYSHORE HIGHWAY, SUITE 200 CITY: BURLINGAME STATE: CA ZIP: 94010 BUSINESS PHONE: 650-701-7901 MAIL ADDRESS: STREET 1: 1555 BAYSHORE HIGHWAY, SUITE 200 CITY: BURLINGAME STATE: CA ZIP: 94010 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2021-03-17 0 0001561743 Kindred Biosciences, Inc. KIN 0001593865 Bevers Denise C/O KINDRED BIOSCIENCES, INC. 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010 1 0 0 0 Common Stock 2021-03-17 4 M 0 8396 0.32 A 8396 I By SD Scientific, Inc. Common Stock 2021-03-17 4 S 0 8396 5.002 D 0 I By SD Scientific, Inc. Common Stock 143835 D Stock Option (right to buy) 0.32 2021-03-17 4 M 0 8396 0 D 2013-05-09 2023-05-09 Common Stock 8396 0 I By SD Scientific, Inc. Held by SD Scientific, Inc. ("SD Scientific"). The Reporting Person is a co-director and co-stockholder of SD Scientific and, as such shares voting and dispositive power over such shares held by SD Scientific but disclaims beneficial ownership of the shares except to the extent of her pecuniary interest therein. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 16, 2020. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.00 to $5.015, inclusive. The Reporting Person undertakes to provide to Kindred Biosciences, Inc., any security holder of Kindred Biosciences, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) to this Form 4. /s/ Denise Bevers 2021-03-18